Gene · 4144
Papers1,624
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,624
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting MTAP increases PARP inhibitor susceptibility in triple-negative breast cancer through a feed-forward loop. | J Clin Invest | 2025 | 40590219 | PubTator, text mining | PubMed |
| Norcantharidin inhibits the METTL16/MAT2A pathway to induce apoptosis and suppress tumor progression in ovarian cancer. | Arch Biochem Biophys | 2025 | 40517800 | PubTator, text mining | PubMed |
| Combined inhibition by PRMT5 and MAT2A demonstrates a strong synthetic lethality in MTAP homozygous-deficient glioma models. | Cell Death Discov | 2025 | 40450009 | PubTator, text mining | PubMed |
| Discovery of Potential Scaffolds for Methionine Adenosyltransferase 2A (MAT2A) Inhibitors: Virtual Screening, Synthesis, and Biological Evaluation. | Molecules | 2025 | 40430308 | PubTator, text mining | PubMed |
| Deciphering the molecular heterogeneity of soft tissue sarcoma by integrating multiomics and single cell sequence. | Int J Biochem Cell Biol | 2025 | 40381905 | PubTator, text mining | PubMed |
| Histone modifications and metabolic reprogramming in tumor-associated macrophages: a potential target of tumor immunotherapy. | Front Immunol | 2025 | 40375990 | PubTator, text mining | PubMed |
| Comprehensive bioinformatics analysis of MEX3 family genes in hepatocellular carcinoma. | Sci Rep | 2025 | 40374855 | PubTator, text mining | PubMed |
| The complex post-transcriptional regulation of genes coding for methionine adenosyl transferase: New insights for liver cancer. | Biochimie | 2025 | 40348354 | PubTator, text mining | PubMed |
| PRPS2 enhances RNA m6A methylation by stimulating SAM synthesis through enzyme-dependent and independent mechanisms. | Nat Commun | 2025 | 40295500 | PubTator, text mining | PubMed |
| S-adenosylmethionine addiction confers sensitivity to methionine restriction in KMT2A-rearranged acute lymphoblastic leukemia. | Haematologica | 2025 | 40270205 | PubTator, text mining | PubMed |
| Structure-Based Discovery of a Series of Novel MAT2a Inhibitors. | ACS Med Chem Lett | 2025 | 40236535 | PubTator, text mining | PubMed |
| E-FTMap: A Protein Structure Based Pharmacophore Identification Server for Guiding Fragment Expansion. | J Mol Biol | 2025 | 40133782 | PubTator, text mining | PubMed |
| Methionine cycle inhibition disrupts antioxidant metabolism and reduces glioblastoma cell survival. | J Biol Chem | 2025 | 40015640 | PubTator, text mining | PubMed |
| Potential Common Molecular Mechanisms Between Periodontitis and Prostate Cancer: A Network Analysis of Differentially Expressed miRNAs. | In Vivo | 2025 | 40010958 | PubTator, text mining | PubMed |
| Single-cell analysis of neoplastic plasma cells identifies myeloma pathobiology mediators and potential targets. | Cell Rep Med | 2025 | 39855192 | PubTator, text mining | PubMed |
| Discovery of Novel Spirocyclic MAT2A Inhibitors Demonstrating High In Vivo Efficacy in MTAP-Null Xenograft Models. | J Med Chem | 2025 | 39835703 | PubTator, text mining | PubMed |
| Advances in Novel Targeted Therapies for Pancreatic Adenocarcinoma. | J Gastrointest Cancer | 2025 | 39762686 | PubTator, text mining | PubMed |
| MAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: a phase I trial. | Nat Commun | 2025 | 39762248 | PubTator, text mining | PubMed |
| Discovery of 2(1H)-Quinoxalinone Derivatives as Potent and Selective MAT2A Inhibitors for the Treatment of MTAP-Deficient Cancers. | J Med Chem | 2025 | 39760448 | PubTator, text mining | PubMed |
| SARS-CoV-2 and HCoV-OC43 regulate host m6A modification via activation of the mTORC1 signalling pathway to facilitate viral replication. | Emerg Microbes Infect | 2025 | 39745173 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4144/papers?page=5